Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events.

E Bendstrup; W Wuyts; T Alfaro; N Chaudhuri; R Cornelissen; M Kreuter; Nielsen K Melgaard; AB Münster; M Myllärniemi; C Ravaglia; T Vanuytsel; M Wijsenbeek

doi:10.1159/000495046

Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events.

E Bendstrup, W Wuyts, T Alfaro, N Chaudhuri, R Cornelissen, M Kreuter, Nielsen K Melgaard, AB Münster, M Myllärniemi, C Ravaglia, T Vanuytsel, M Wijsenbeek

Research output: Contribution to journal › Comment/debate › peer-review

48 Citations (Scopus)

Original language	English
Journal	Respiration; international review of thoracic diseases
DOIs	https://doi.org/10.1159/000495046
Publication status	Published (in print/issue) - Dec 2018

Access to Document

10.1159/000495046

Cite this

Bendstrup, E., Wuyts, W., Alfaro, T., Chaudhuri, N., Cornelissen, R., Kreuter, M., Melgaard, N. K., Münster, AB., Myllärniemi, M., Ravaglia, C., Vanuytsel, T., & Wijsenbeek, M. (2018). Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events. Respiration; international review of thoracic diseases. https://doi.org/10.1159/000495046

@article{fcc1960d00724a9ba9ffd161bbae9e3f,

title = "Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events.",

author = "E Bendstrup and W Wuyts and T Alfaro and N Chaudhuri and R Cornelissen and M Kreuter and Melgaard, {Nielsen K} and AB M{\"u}nster and M Myll{\"a}rniemi and C Ravaglia and T Vanuytsel and M Wijsenbeek",

year = "2018",

month = dec,

doi = "10.1159/000495046",

language = "English",

}

Bendstrup, E, Wuyts, W, Alfaro, T, Chaudhuri, N, Cornelissen, R, Kreuter, M, Melgaard, NK, Münster, AB, Myllärniemi, M, Ravaglia, C, Vanuytsel, T & Wijsenbeek, M 2018, 'Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events.', Respiration; international review of thoracic diseases. https://doi.org/10.1159/000495046

TY - JOUR

T1 - Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events.

AU - Bendstrup, E

AU - Wuyts, W

AU - Alfaro, T

AU - Chaudhuri, N

AU - Cornelissen, R

AU - Kreuter, M

AU - Melgaard, Nielsen K

AU - Münster, AB

AU - Myllärniemi, M

AU - Ravaglia, C

AU - Vanuytsel, T

AU - Wijsenbeek, M

PY - 2018/12

Y1 - 2018/12

UR - http://europepmc.org/abstract/med/30544129

U2 - 10.1159/000495046

DO - 10.1159/000495046

M3 - Comment/debate

C2 - 30544129

JO - Respiration; international review of thoracic diseases

JF - Respiration; international review of thoracic diseases

ER -

Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events.

Access to Document

Other files and links

Cite this